1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Midnight Pharma, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia almorexant, Placebo, zolpidem - Primary Insomnia | Phase 3 | Completed | Midnight Pharma, LLC | 709 | 2008-03-01 | 2016-03-14 |
Sleep Initiation and Maintenance Disorders (1)
Zolpidem (1) · almorexant (1)
Australia (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Poland (1) · Slovakia (1) · South Africa (1)